United States· US:68001-489_4dc25344-d257-6634-e063-6394a90a2f40
Abiraterone
A abiraterone product containing abiraterone acetate, registered in United States by BluePoint Laboratories. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Abiraterone is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BX03 (abiraterone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Abiraterone · ATC L02BX03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abiraterone costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Abiraterone · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$42.72
- FR France$33.07
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ABIRATERONE ACETATE
- Manufacturer
- BluePoint Laboratories
- Country
- United States (US)
- ATC code
- L02BX03
- ATC class
- Abiraterone
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168001-489-07
- ndc116800148907120 TABLET in 1 BOTTLE (68001-489-07)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
461 interactions on record for abiraterone.
Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Abiraterone · interactions on record
461 records
- 101 severe
- 335 moderate
- 25 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LoperamideA07DA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Abiraterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainABIRATERONA ACCORD 250 MG COMPRIMIDOS EFGAccord Healthcare S.L.U.
- CanadaAPO-ABIRATERONE FILM COATED TABLETSAPOTEX INC
- NetherlandsAbirateron betapharm 250 mg, tablettenBetapharm Arzneimittel GmbH
- PolandAbirateron AristoAristo Pharma Sp. z o.o.
- CzechiaABIRATERONE ABDIAbdi Farma GmbH, Heppenheim
- United KingdomAbiraterone 250mg tabletsCrescent Pharma Ltd
- FinlandAbirateron AvansorAvansor Pharma Oy
- IrelandAbiraterone Accord 250 mg tabletsAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Abiral, Abirateron +pharma
- Belgium · Abirateron Eg, Abirateronacetaat Eg (Eurogenerics) Nv
- Bulgaria · Абиратерон Msn, Абиратерон Деватис
- Cyprus · Abiraterone Farmoz, Abiraterone Pharmazac
- Czechia · Abirateron Ashcure, Abirateron Pharmagen
- Germany · Abibam®, Abiranio
- Denmark · Abirateron "olpha", Abirateron "sandoz"
- Estonia · Abiraterone G.L. Pharma, Abiraterone Norameda
- Spain · Abiraterona Ashcure, Abiraterona Cipla
- Finland · Abirateron Avansor, Abirateron Devatis
- France · Abiraterone Acetate Zydus, Abiraterone Arrow
- United Kingdom (Northern Ireland) · Abiraterone, Abiraterone Abdi
- Greece · Abinone, Abiprostem
- Croatia · Abirateron Alpha-Medical, Abirateron Devatis
- Hungary · Abaxan, Abirateron Galenika
- Ireland · Abiraterone, Abiraterone Aristo
- Iceland · Abirateron, Abirateron Medical Valley
- Italy · Abiraterone Abdi, Abiraterone Abdi Farma
- Liechtenstein · Abiraterone Accord, Abiraterone Mylan
- Lithuania · Abiraterone G.L. Pharma, Abiraterone Norameda
- Luxembourg · Abirateron Eg, Abiraterone Eugia
- Latvia · Abiraterone G.L. Pharma, Abiraterone Norameda
- Malta · Abiraterone Ashcure, Abiraterone Clonmel
- Netherlands · Abirateron 1a Pharma, Abirateron Abdi
- Norway · Abirateron Devatis, Abirateron Medical Valley
- Poland · Abiral, Abirateron Sun
- Portugal · Abiraterona Bluepharma, Abiraterona Eugia
- Romania · Abirateron? Lannacher, Abirateronă
- Sweden · Abirateron Devatis, Abirateron Medical Valley
- Slovenia · Abirateron Galenika, Abirateron Teva
- Slovakia · Abirateron Msn, Abirateron Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3e8776e-03bb-447e-813a-11719f06eb94 GET /v1/drugs/b3e8776e-03bb-447e-813a-11719f06eb94?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250",
"substance": "ABIRATERONE ACETATE",
"productndc": "68001-489",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA210686",
"marketing_category": "ANDA"
}See everything about abiraterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.